Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

Selenium is essential for health, but too little or too much can cause serious health problems.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

PCOS women with COVID-19 have higher cardiometabolic risks.

Women with PCOS may be more susceptible to COVID-19 due to hormonal and psychological factors.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.